M-current preservation contributes to anticonvulsant effects of valproic acid
Open Access
- 8 September 2015
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 125 (10) , 3904-3914
Abstract
Valproic acid (VPA) has been widely used for decades to treat epilepsy; however, its mechanism of action remains poorly understood. Here, we report that the anticonvulsant effects of nonacute VPA treatment involve preservation of the M-current, a low-threshold noninactivating potassium current, during seizures. In a wide variety of neurons, activation of Gq-coupled receptors, such as the m1 muscarinic acetylcholine receptor, suppresses the M-current and induces hyperexcitability. We demonstrated that VPA treatment disrupts muscarinic suppression of the M-current and prevents resultant agonist-induced neuronal hyperexcitability. We also determined that VPA treatment interferes with M-channel signaling by inhibiting palmitoylation of a signaling scaffold protein, AKAP79/150, in cultured neurons. In a kainate-induced murine seizure model, administration of a dose of an M-channel inhibitor that did not affect kainate-induced seizure transiently eliminated the anticonvulsant effects of VPA. Retigabine, an M-channel opener that does not open receptor-suppressed M-channels, provided anticonvulsant effects only when administered prior to seizure induction in control animals. In contrast, treatment of VPA-treated mice with retigabine induced anticonvulsant effects even when administered after seizure induction. Together, these results suggest that receptor-induced M-current suppression plays a role in the pathophysiology of seizures and that preservation of the M-current during seizures has potential as an effective therapeutic strategy.Keywords
This publication has 54 references indexed in Scilit:
- ATP Competitive Protein Kinase C Inhibitors Demonstrate Distinct State-Dependent InhibitionPLOS ONE, 2011
- The role of norepinephrine in epilepsy: from the bench to the bedsideNeuroscience & Biobehavioral Reviews, 2004
- Bipolar DisorderNew England Journal of Medicine, 2004
- Newly developed blockers of the M‐current do not reduce spike frequency adaptation in cultured mouse sympathetic neuronsEuropean Journal of Neuroscience, 2004
- Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5‐HT1A receptorsJournal of Neurochemistry, 2004
- Calmodulin Mediates Ca2+-dependent Modulation of M-type K+ ChannelsJournal of General Physiology, 2003
- The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunitsNeuroscience Letters, 2000
- Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture.The Journal of Pharmacology and Experimental Therapeutics, 1986
- Effects of In Vivo Administration of Kainic Acid on the Extracellular Amino Acid Pool in the Rabbit HippocampusJournal of Neurochemistry, 1983
- Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.The Journal of Pharmacology and Experimental Therapeutics, 1982